Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-23

Clinical Trial Update: Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating a four-drug chemotherapy regimen (gemcitabine, paclitaxel, ifosfamide, and cisplatin) for progressive or relapsed metastatic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CISPLATIN (cisplatin)
  • Gemcitabine (Gemcitabine)
  • IFOSFAMIDE (IFOSFAMIDE)
  • PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: University of Southampton | Conditions: Brain and Central Nervous System Tumors, Extragonadal Germ Cell Tumor | Phase 1, Phase 2 | Status: UNKNOWN